The quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer in clinical trials as the current 30- to 40-minute scan.

Multiparametric MRI was a game changer for prostate cancer diagnosis. Now trial findings suggest a simpler imaging protocol may be as effective.

Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have preliminarily validated an artificial intelligence (AI) tool to predict ...

A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30–40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, ...

Discover a study showing that biparametric MRI is as effective as multiparametric MRI in detecting clinically significant ...

There is both good news and bad news about prostate cancer screening. First, the bad news: the blood test involved, which measures a compound called prostate-specific antigen (PSA), is too inaccurate.

It might not seem much in the world of medical research, but clinical trial results on the use of MRI scans in prostate cancer could have huge implications for millions of men. Published today in the ...

Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated “classic” neurovascular bundle patterns and over 96% showed more than ...